A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome

Reproductive Sciences

Volumn 19, Issue 8, 2012, Pages 863-875

  Heazell, Alexander E P ^a,b,c   Bernatavicius, Giovanna ^a   Warrander, Lynne ^a   Brown, Marie C ^a,c   Dunn, Warwick B ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Manchester NIHR Biomedical Research Centre   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

fetal growth restriction; lipids; metabolomics; preterm birth; progesterone; vitamin D

Indexed keywords

2 HYDROXYNONACOSANOIC ACID; DIMETHYLPENTACOSENOIC ACID; EPOXYSTEARIC ACID; ETHYLACRYLIC ACID; FATTY ACID; GLYCEROLIPID; GLYCEROPHOSPHOLIPID; HEPTACOSANOIC ACID; HEPTACOSENOIC ACID; HEXACOSANEDIOIC ACID; HYDROXYDODECANOIC ACID; HYDROXYHEXACOSANOIC ACID; HYDROXYOCTADECENOIC ACID; LIPID; METHYL DIHYDROPEROXYOCTADECATRIENOIC ACID; METHYL HEXACOSENOIC ACID; METHYLDOCOSANOIC ACID; METHYLHEXACOSANOIC ACID; NONACOSANOIC ACID; NONENOIC ACID; PENTACOSENOIC ACID; PROGESTERONE; SPHINGOLIPID; STEARIC ACID; STEROL; STEROL LIPID DERIVATIVE; TRICOSANOIC ACID; TRIMETHYL TETRACOSADIENOIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; MASS SPECTROMETRY; MATERNAL SERUM; METABOLOMICS; NEWBORN INTENSIVE CARE; PERINATAL PERIOD; PLACENTA DISORDER; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; GESTATIONAL AGE; GLYCOLIPIDS; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INTENSIVE CARE, NEONATAL; METABOLOMICS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH; PROGESTERONE; PROSPECTIVE STUDIES; STEROLS;

EID: 84864372049     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112438446     Document Type: Article

References (36)

1. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011 ; 204 (3). 193-201
2. Perinatal Mortality 2007: England, Wales and Northern Ireland. London: Confidential Enquiry into Maternal and Child Health ; 2009 :
3. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ. 2005 ; 331 (7525). 1113-1117 (Pubitemid 41634895)
4. Haws RA, Yakoob MY, Soomro T, Menezes EV, Darmstadt GL, Bhutta ZA. Reducing stillbirths: screening and monitoring during pregnancy and labour. BMC Pregnancy Childbirth. 2009 ; 9 (suppl 1). S5
5. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011 ; 40 (1). 387-426
6. Heazell AE, Brown M, Worton SA, Dunn WB. Review: the effects of oxygen on normal and pre-eclamptic placental tissue-insights from metabolomics. Placenta. 32 (suppl 2). S119 - S124
7. Kenny LC, Broadhurst D, Brown M, et al. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci. 2008 ; 15 (6). 591-597 (Pubitemid 351877082)
8. Kenny LC, Broadhurst DI, Dunn W, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension. 2010 ; 56 (4). 741-749
9. Odibo AO, Goetzinger KR, Odibo L, et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn. 2011 ; 31 (10). 990-994
10. Romero R, Mazaki-Tovi S, Vaisbuch E, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med. 2010 ; 23 (12). 1344-1359
11. Graca G, Duarte IF, Barros AS, et al. Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study. J Proteome Res. 2010 ; 9 (11). 6016-6024
12. Heazell AE, Brown M, Dunn WB, et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta. 2008 ; 29 (8). 691-698
13. Dunn WB, Brown M, Worton SA, et al. Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta. 2009 ; 30 (11). 974-980
14. Horgan RP, Broadhurst DI, Dunn WB, et al. Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta. 2009 ; 31 (10). 893-901
15. Warrander LK, Kroll J, Greenwood SL, Sibley CP, Jones RL, Heazell AEP. Placentally-derived factors may be used to predict poor pregnancy outcome in reduced fetal movements. Arch Dis Child Fetal Neonatal Ed. 2011 ; 96: Fa12
16. Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011 ; 6 (7). 1060-1083
17. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006 ; 78 (3). 779-787 (Pubitemid 43228585)
18. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics. 2007 ; 3: 211-221
19. Brown M, Wedge DC, Goodacre R, et al. Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics. 2011 ; 27 (8). 1108-1112
20. Redline RW. Clinically and biologically relevant patterns of placental inflammation. Pediatr Dev Pathol. 2002 ; 5 (4). 326-328
21. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta. 2007 ; 28 (suppl A). S33 - S40
22. Vcelakova H, Hill M, Lapcik O, Parizek A. Determination of 17alpha-hydroxypregnenolone sulfate and its application in diagnostics. Steroids. 2007 ; 72 (4). 323-327 (Pubitemid 46452710)
23. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006 ; 47 (2). 203-208 (Pubitemid 43189764)
24. Ligam P, Manuelpillai U, Wallace EM, Walker D. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. Placenta. 2005 ; 26 (6). 498-504 (Pubitemid 40796578)
25. Kamimura S, Eguchi K, Yonezawa M, Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama. 1991 ; 45 (3). 135-139
26. Kudo Y, Boyd CA. Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim Biophys Acta. 2000 ; 1500 (1). 119-124 (Pubitemid 29525405)
27. Dunn WB, Brown M, Worton SA, et al. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy. Metabolomics. 2011 ;:
28. How HY, Cook CR, Cook VD, et al. The pattern of change in the lecithin/sphingomyelin ratio in patients with preterm premature rupture of membranes between 24 and 34 weeks' gestation. J Perinatol. 2002 ; 22 (1). 21-25 (Pubitemid 34162944)
29. Torrance HL, Voorbij HA, Wijnberger LD, van Bel F, Visser GH. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev. 2008 ; 84 (7). 465-469
30. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008 ; 9 (2). 162-176 (Pubitemid 351158917)
31. Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol. 2011 ; 204 (6). e551 - e554
32. Baker AM, Haeri S, Camargo CA, Stuebe AM, Boggess KA. A nested case-control study of first-trimester maternal vitamin D status and risk for spontaneous preterm birth. Am J Perinatol. 2011 ; 28 (9). 667-672
33. Specker BL. Does vitamin D during pregnancy impact offspring growth and bone?. Proc Nutr Soc. 2012 ; 71 (1). 38-45
34. Bodnar LM, Catov JM, Zmuda JM, et al. Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr. 2010 ; 140 (5). 999-1006
35. Brough L, Rees GA, Crawford MA, Morton RH, Dorman EK. Effect of multiple-micronutrient supplementation on maternal nutrient status, infant birth weight and gestational age at birth in a low-income, multi-ethnic population. Br J Nutr. 2010 ; 104 (3). 437-445
36. Horgan RP, Clancy OH, Myers JE, Baker PN. An overview of proteomic and metabolomic technologies and their application to pregnancy research. BJOG. 2009 ; 116 (2). 173-181